Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Cyproterone acetate can cause rare shortness of breath in women.

Possible link between androgens and COVID-19 severity; more research needed.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Removing both ovaries treated the woman's excess male hormone symptoms.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

The study concludes that Twenty-nail dystrophy is more common in boys among children and in women among adults, with varying response to treatment.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.